The U.S. International Trade Commission instituted a Section 337 investigation on April 14, 2026, based on a complaint filed by J.A.R. Laboratories LLC alleging infringement of U.S. Patent No. 12,109,181 through importation of certain over-the-counter topical lidocaine patches. The complainant seeks a limited exclusion order and cease and desist orders. No respondent countries were specified in the institution notice.

Daily Signals alert

Get relevant trade-policy alerts in Daily Trade Signals.

Subscription scopeDaily Trade SignalsThe daily email, with this source context saved for matching.Only Section 337Filter future fragments toward this policy instrument.This HS code or caseFollow changes linked to HS 30.

Subscribes you to Daily Trade Signals and stores this source page, selected scope, and a timestamp for alert matching. Unsubscribe anytime. See our privacy policy.

Review Snapshot

Scope: HS 30 / Section 337
Question: Does this source change alter exposure, timing, or review priority for HS 30 / Section 337?
Next move: Check HS 30 in Tariffs, then save the scope if this question repeats.

Legal / Policy Context

Policy instruments

Section 337

Practical Takeaways

Check the tagged HS codes in tariff context before treating this as a general market signal.
Use Paths to see adjacent source records, countries, and instruments before escalating this as a standalone change.

Source Trail

USITCPrimary briefing source

Open source